These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 2163713)

  • 1. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
    Pettifor JM
    Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
    Lyles KW; Drezner MK
    J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
    Aarskog D; Aksnes L; Markestad T
    Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
    Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y
    Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats.
    Ikeda K; Matsumoto T; Morita K; Yamato H; Takahashi H; Ezawa I; Ogata E
    Endocrinology; 1987 Nov; 121(5):1721-6. PubMed ID: 3311717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology.
    Caniggia A; Lorè F; di Cairano G; Nuti R
    J Steroid Biochem; 1987; 27(4-6):815-24. PubMed ID: 3320561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Jones G
    J Clin Invest; 1990 May; 85(5):1450-5. PubMed ID: 2332500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH
    Metabolism; 1990 Apr; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.
    Nesbitt T; Drezner MK; Lobaugh B
    J Clin Invest; 1986 Jan; 77(1):181-7. PubMed ID: 3753708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
    Alon US; Levy-Olomucki R; Moore WV; Stubbs J; Liu S; Quarles LD
    Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.
    Yasuda T; Nakajima H
    Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.